Catalio Capital Management
Overview
A multi-strategy investment firm focused on breakthrough biomedical technology and innovative healthcare companies worldwide Our mission is to produce extraordinary returns by creating and sustaining life sciences companies that combine the best science and technology with the best management and execution. To achieve this objective, we work with an elite group of the world’s best scientists, engineers and clinicians – the Catalio Venture Partners – to identify breakthrough biotechnologies; co-invest with top-tier funds; and recruit A-list talent from our collective networks.
Investment Focus
- Focus on healthcare and biotechnology sectors
- Preference for companies with innovative biomedical technologies
- Interest in both private equity and venture capital stages
- Global operational scope with offices in New York, Washington D.C., and London
- Collaboration with a network of over 45 venture partners, including Nobel Prize winners and serial scientist-entrepreneurs
- Investment strategy centers on identifying and supporting transformative biomedical companies at all stages
- Leverages scientific expertise and extensive advisor network to evaluate and back companies deeply
- Completed more than 20 exits since its founding, including ArriVent BioPharma, Recursion Pharmaceuticals, Thrive Earlier Detection, and Haystack Oncology
Portfolio Companies
Reach Catalio Capital Management directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Catalio Capital Management
What sectors does Catalio Capital Management invest in?
Catalio Capital Management invests in Healthcare, Life Sciences, Pharmaceuticals, Medical Devices, Diagnostics and Biotechnology, and is based in Baltimore,Maryland. Catalio Capital Management is listed as a vc in the ConnectSafely investor database.
What stage does Catalio Capital Management invest at?
Catalio Capital Management backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 10M - 50M.
Which regions does Catalio Capital Management invest in?
Catalio Capital Management invests across United States, United Kingdom, Canada, Germany, Hong Kong and Japan.
Who are the partners at Catalio Capital Management?
Team members listed for Catalio Capital Management include George Petrocheilos (Co-Founder & Managing Partner) and Jacob Vogelstein (Co-Founder and Managing Partner).
What companies has Catalio Capital Management invested in?
Catalio Capital Management's portfolio includes Recursion Pharmaceuticals, Alentis Therapeutics, Imperative Care, PinkDx, Superluminal Medicines, Rhapsogen, TBD Pharma and Protara Therapeutics.
How do I contact Catalio Capital Management?
Catalio Capital Management's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database